Genetic Variants in HSD17B3 , SMAD3 , and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes-Reference-Cited by-同舟云学术

Genetic Variants in HSD17B3 , SMAD3 , and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

Published:2017-11-03 Issue:4 Volume:103 Page:712-721
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Rotroff Daniel M.¹²,Pijut Sonja S.³,Marvel Skylar W.¹,Jack John R.¹,Havener Tammy M.⁴,Pujol Aurora⁵⁶,Schluter Agatha⁵,Graf Gregory A.³⁷⁸,Ginsberg Henry N.⁹,Shah Hetal S.¹⁰,Gao He¹⁰,Morieri Mario‐Luca¹⁰,Doria Alessandro¹⁰,Mychaleckyi Josyf C.¹¹^ORCID,McLeod Howard L.¹²,Buse John B.¹³,Wagner Michael J.⁴,Motsinger‐Reif Alison A.¹²,

Affiliation:

1. Bioinformatics Research CenterNorth Carolina State UniversityRaleigh North Carolina USA

2. Department of StatisticsNorth Carolina State UniversityRaleigh North Carolina USA

3. Department of Pharmaceutical SciencesUniversity of KentuckyLexington Kentucky USA

4. Center for Pharmacogenomics and Individualized TherapyUniversity of North Carolina Chapel HillChapel Hill North Carolina USA

5. Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), and CIBERER U759Center for Biomedical Research on Rare DiseasesBarcelona Spain

6. Catalan Institution for Research and Advanced Studies (ICREA)Barcelona Spain

7. Center for Pharmaceutical Research and InnovationUniversity of KentuckyLexington Kentucky USA

8. Saha Cardiovascular Research CenterUniversity of KentuckyLexington Kentucky USA

9. Irving Institute for Clinical and Translational ResearchColumbia University College of Physicians and SurgeonsNew York New York USA

10. Joslin Diabetes Center and Harvard Medical SchoolBoston Massachusetts USA

11. Center for Public Health GenomicsUniversity of VirginiaCharlottesville Virginia USA

12. Moffitt Cancer CenterTampa Florida USA

13. Division of EndocrinologyUniversity of North Carolina School of MedicineChapel Hill North Carolina USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.798

Reference50 articles.

1. WHO; World Heart Federation; World Stroke Organization eds.Global atlas on cardiovascular disease prevention and control. Policies strategies and interventions(World Health Organization 2011). (2011).

2. Heart Disease and Stroke Statistics—2016 Update

3. The role of fibrates in the prevention of cardiovascular disease—a pooled meta-analysis of long-term randomized placebo-controlled clinical trials

4. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

5. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction;Scientific Reports;2024-02-10

3. Drug development advances in human genetics‐based targets;MedComm;2024-02

4. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis;2023-12-07

5. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk;Genes;2023-11-09